October 22nd, 2008 
Von by Beverly Natividad
THE BUREAU OF FOOD AND DRUGS has ordered the recall of the pain-killing drug Lumiracoxib (Prexige) because of its potential side effects to the liver.
In an advisory, the BFAD said it has ordered drug company Novartis Healthcare Phils. Inc. to “cease and desist from further importing, distributing or selling Lumiracoxib (Prexige),” said BFAD director Letecia Barbara B. Gutierrez.
It also ask the public to stop taking the drug and their physicians to recommend alternative treatment.
The BFAD said the recall is due to reports abroad of potential serious liver-related side effects asociated with the use of Lumiracoxib. The drug is used to treat osteoarthritis and for the short term relief of moderate to severe acute pain associated with primary dysmenorrheal, dental and orthopedic surgery.
In a statement, Norvatis said it has complied with the BFAD order and has recalled Lumiracoxib tablets from the market. (more…)
Posted in 
Tags: 
